Gregory Y.H. Lip

306.9k total citations · 45 hit papers
3.0k papers, 120.3k citations indexed

About

Gregory Y.H. Lip is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Gregory Y.H. Lip has authored 3.0k papers receiving a total of 120.3k indexed citations (citations by other indexed papers that have themselves been cited), including 2.5k papers in Cardiology and Cardiovascular Medicine, 652 papers in Internal Medicine and 490 papers in Epidemiology. Recurrent topics in Gregory Y.H. Lip's work include Atrial Fibrillation Management and Outcomes (1.9k papers), Cardiac Arrhythmias and Treatments (933 papers) and Venous Thromboembolism Diagnosis and Management (652 papers). Gregory Y.H. Lip is often cited by papers focused on Atrial Fibrillation Management and Outcomes (1.9k papers), Cardiac Arrhythmias and Treatments (933 papers) and Venous Thromboembolism Diagnosis and Management (652 papers). Gregory Y.H. Lip collaborates with scholars based in United Kingdom, Denmark and United States. Gregory Y.H. Lip's co-authors include Deirdre A. Lane, Andrew D. Blann, Harry J.G.M. Crijns, Robby Nieuwlaat, Ron Pisters, Eduard Shantsila, Torben Bjerregaard Larsen, Jonathan L. Halperin, Francisco Marı́n and Flemming Skjøth and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Gregory Y.H. Lip

2.9k papers receiving 117.2k citations

Hit Papers

Refining Clinical Risk Stratification for Predicting Stro... 2006 2026 2012 2019 2009 2010 2016 2006 2007 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
    2009 4.9k citations Gregory Y.H. Lip et al. profile →
  2. A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
    2010 3.2k citations Gregory Y.H. Lip et al. profile →
  3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
    2016 1.8k citations José Luis Zamorano, Patrizio Lancellotti et al. European Heart Journal profile →
  4. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
    2006 1.4k citations Gregory Y.H. Lip et al. European Heart Journal profile →
  5. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    2007 1.1k citations Jonathan Mant, Gregory Y.H. Lip et al. profile →
  6. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
    2011 1.1k citations Jonas Bjerring Olesen, Gregory Y.H. Lip et al. profile →
  7. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
    2013 946 citations Gregory Y.H. Lip et al. European Heart Journal profile →
  8. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
    2016 942 citations Gregory Y.H. Lip, Steen Husted et al. profile →
  9. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
    2017 843 citations Gregory Y.H. Lip et al. profile →
  10. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
    2012 824 citations Leif Friberg, Gregory Y.H. Lip et al. European Heart Journal profile →
  11. Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
    2010 770 citations Gregory Y.H. Lip et al. profile →
  12. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
    2009 744 citations Eduard Shantsila, Gregory Y.H. Lip et al. profile →
  13. Antithrombotic Therapy for Atrial Fibrillation
    2012 697 citations Gregory Y.H. Lip et al. profile →
  14. Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
    2010 687 citations Gregory Y.H. Lip et al. profile →
  15. Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
    2012 674 citations Jonas Bjerring Olesen, Gregory Y.H. Lip et al. profile →
  16. Antithrombotic Therapy for Atrial Fibrillation
    2018 637 citations Gregory Y.H. Lip, Amitava Banerjee et al. profile →
  17. Inflammation in Atrial Fibrillation
    2012 634 citations Gregory Y.H. Lip, Stavros Apostolakis et al. profile →
  18. Antithrombotic Therapy in Atrial Fibrillation
    2008 569 citations Gregory Y.H. Lip et al. profile →
  19. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation
    2012 553 citations Gregory Y.H. Lip et al. profile →
  20. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society
    2015 520 citations Gregory Y.H. Lip et al. profile →
  21. Quality of Life in Patients with Atrial Fibrillation: A Systematic Review
    2006 487 citations Gregory Y.H. Lip et al. profile →
  22. Cardiac Fibrosis in Patients With Atrial Fibrillation
    2015 422 citations Gregory Y.H. Lip, Eduard Shantsila et al. profile →
  23. The ABC pathway: an integrated approach to improve AF management
    2017 401 citations Gregory Y.H. Lip profile →
  24. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
    2014 363 citations Gregory Y.H. Lip et al. profile →
  25. Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
    2013 343 citations Gregory Y.H. Lip et al. profile →
  26. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    2016 342 citations Gregory Y.H. Lip et al. profile →
  27. Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
    2013 331 citations Stavros Apostolakis, Renee M. Sullivan et al. profile →
  28. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
    2021 301 citations Seil Oh, Gregory Y.H. Lip et al. profile →
  29. Stroke prevention in atrial fibrillation
    2016 291 citations Gregory Y.H. Lip et al. profile →
  30. Stroke prevention in atrial fibrillation: Past, present and future
    2017 275 citations Gregory Y.H. Lip et al. profile →
  31. Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients
    2021 275 citations Giulio Francesco Romiti, Wern Yew Ding et al. profile →
  32. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    2017 258 citations Gregory Y.H. Lip et al. profile →
  33. Atrial fibrillation
    2022 254 citations Gregory Y.H. Lip et al. profile →
  34. Ferritinophagy and ferroptosis in the management of metabolic diseases
    2021 251 citations Gregory Y.H. Lip et al. profile →
  35. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
    2020 211 citations Gregory Y.H. Lip, Laurent Fauchier et al. profile →
  36. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
    2020 187 citations Gregory Y.H. Lip et al. profile →
  37. Atrial fibrillation: epidemiology, screening and digital health
    2024 137 citations Gregory Y.H. Lip et al. profile →
  38. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association
    2022 132 citations Gregory Y.H. Lip et al. Circulation profile →
  39. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics
    2023 99 citations Gregory Y.H. Lip et al. profile →
  40. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
    2023 79 citations Gregory Y.H. Lip, Marco Proietti et al. profile →
  41. Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study
    2024 43 citations Gregory Y.H. Lip et al. profile →
  42. Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis
    2024 42 citations Gregory Y.H. Lip et al. profile →
  43. Racial Differences in Bleeding Risk: An Ecological Epidemiological Study Comparing Korea and United Kingdom Subjects
    2024 42 citations Gregory Y.H. Lip et al. profile →
  44. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort
    2024 41 citations Gregory Y.H. Lip et al. profile →
  45. Atrial fibrillation: stroke prevention
    2024 37 citations Gregory Y.H. Lip et al. profile →

Peers

Gregory Y.H. Lip
Comparison fields: 5 of 217
  • Cardiology and Cardiovascular Medicine 93.1k
  • Internal Medicine 26.1k
  • Epidemiology 18.4k
  • Surgery 11.3k
  • Radiology, Nuclear Medicine and Imaging 8.2k
Replace Salim Yusuf with:
Salim Yusuf Canada
Gregg C. Fonarow United States
Deepak L. Bhatt United States
Eric D. Peterson United States
Philippe Gabríel Steg France
Christopher B. Granger United States
Eugene Braunwald United States
Emelia J. Benjamin United States
Mary Cushman United States
Bernard J. Gersh United States
Salim Yusuf Canada View profile →
Citations per field, relative to Gregory Y.H. Lip
Gregory Y.H. Lip · 1×
Citations per year, relative to Gregory Y.H. Lip
Gregory Y.H. Lip · 1×

Countries citing papers authored by Gregory Y.H. Lip

Since Specialization
Citations

This map shows the geographic impact of Gregory Y.H. Lip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Y.H. Lip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Y.H. Lip more than expected).

Fields of papers citing papers by Gregory Y.H. Lip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Y.H. Lip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Y.H. Lip. The network helps show where Gregory Y.H. Lip may publish in the future.

Co-authorship network of co-authors of Gregory Y.H. Lip

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Y.H. Lip. A scholar is included among the top collaborators of Gregory Y.H. Lip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Y.H. Lip. Gregory Y.H. Lip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Fibrinaloid Microclots and Atrial Fibrillation
2024 ·Biomedicines ·Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
4
2
Corrigendum to “Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis” [General Hospital Psychiatry volume 88 (2024)10–22 10.1016/j.genhosppsych.2024.02.009]
2024 ·General Hospital Psychiatry ·Christina M. van der Feltz‐Cornelis, Fidan Türk, (unknown), Kamlesh Khunti, Mark Gabbay, (unknown), Hugh Montgomery, W. David Strain, Gregory Y.H. Lip, Dan Wootton, Caroline Watkins, Daniel J. Cuthbertson, Nefyn Williams, Amitava Banerjee
1
3
Nuevas estrategias de prevención del ictus tras ablación con catéter de la fibrilación auricular
2024 ·Revista Española de Cardiología ·Wern Yew Ding, Peter Calvert, Gregory Y.H. Lip, Dhiraj Gupta
2
4
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study
2023 ·American Heart Journal ·Arnaud Bisson, (unknown), Giulio Francesco Romiti, Marco Proietti, Denis Angoulvant, (unknown), Wahbi K. El‐Bouri, Gregory Y.H. Lip, Laurent Fauchier
3
5
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study
2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Xinyi Gao, Nan Zhang, Lei Lü, Tianyu Gao, Oscar Hou In Chou, Wing Tak Wong, Carlin Chang, Abraham Ka Chung Wai, Gregory Y.H. Lip, Qingpeng Zhang, Gary Tse, Tong Liu, Jiandong Zhou
3
6
Neuroticism and sudden cardiac death: a prospective cohort study from UK biobank
2023 ·Clinical Research in Cardiology ·Tae‐Min Rhee, (unknown), (unknown), Eue‐Keun Choi, Hyo‐Jeong Ahn, So‐Ryoung Lee, Seil Oh, Gregory Y.H. Lip
4
7
Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke
2023 ·Frontiers in Cardiovascular Medicine ·(unknown), Gregory Y.H. Lip, David Nordsletten, Steven E. Williams, Oleg Aslanidi, Adelaide de Vecchi
19
8
A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF)
2021 ·International Journal of Clinical Practice ·(unknown), Hooman Bakhshandeh, Reza Golpira, (unknown), (unknown), Zahra Emkanjoo, (unknown), (unknown), Majid Maleki, Gregory Y.H. Lip, Majid Haghjoo
3
9
Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States
2016 ·International Journal of Clinical Practice ·Gregory Y.H. Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Amanda Bruno, Hemant Phatak
93
10
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines breakdown →
2016 ·European Heart Journal ·José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, Daniel J. Lenihan, Gregory Y.H. Lip, Alexander R. Lyon, Teresa López‐Fernández, Dania Mohty, Massimo Piepoli, Juan Tamargo, Adam Torbicki, Thomas Suter
1750
11
Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant
2014 ·Circulation ·Morten Lamberts, Gunnar Gislason, Gregory Y.H. Lip, Jens Flensted Lassen, Jonas Bjerring Olesen, Anders Pretzmann Mikkelsen, Rikke Sørensen, Lars Køber, Christian Torp‐Pedersen, Morten Lock Hansen
181
12
Hormone Replacement Therapy and Adverse Outcomes in Women With Atrial Fibrillation
2014 ·Stroke ·Stavros Apostolakis, Renee M. Sullivan, Brian Olshansky, Gregory Y.H. Lip
15
13
Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation
2013 ·Expert Review of Cardiovascular Therapy ·Aung Myat, Yousif Ahmad, Shouvik Haldar, Udaya S. Tantry, Simon Redwood, Paul A. Gurbel, Gregory Y.H. Lip
2
14
Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
2012 ·Circulation ·Francesco Dentali, Nicoletta Riva, Mark Crowther, Alexander G.G. Turpie, Gregory Y.H. Lip, Walter Ageno
288
15
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
2012 ·Circulation ·Leif Friberg, Mårten Rosenqvist, Gregory Y.H. Lip
318
16
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin
2012 ·Stroke ·Greg C. Flaker, John W. Eikelboom, Olga Shestakovska, Stuart J. Connolly, Scott Kaatz, Andrzej Budaj, Steen Husted, Salim Yusuf, Gregory Y.H. Lip, Robert G. Hart
61
17
Myocardial Perfusion by Myocardial Contrast Echocardiography and Endothelial Dysfunction in Obstructive Sleep Apnea
2011 ·Hypertension ·Mehmood Butt, Omer Khair, Girish Dwivedi, Alena Shantsila, Eduard Shantsila, Gregory Y.H. Lip
44
18
A Randomized Trial of the Addition of Home-Based Exercise to Specialist Heart Failure Nurse Care: The Birmingham Rehabilitation Uptake Maximisation Study for Patients with Congestive Heart Failure (BRUM-CHF) Study
2009 ·European Journal of Heart Failure ·Kate Jolly, Rod S Taylor, Gregory Y.H. Lip, (unknown), Russell Davis, Jonathan Mant, Sally Singh, Sheila Greenfield, (unknown), (unknown), Stirling Bryan, Andrew Stevens
90
19
Increased Circulating Endothelial Cells in Acute Heart Failure: Comparison with Von Willebrand Factor and Soluble E-Selectin
2005 ·European Journal of Heart Failure ·Aun‐Yeong Chong, Gregory Y.H. Lip, Bethan Freestone, Andrew D. Blann
39
20
An 8-Year Follow-Up Study of Acute Admissions with Heart Failure in a Multiethnic Population
2004 ·European Journal of Heart Failure ·Michael Sosin, Gurbir Bhatia, John Zarifis, Russell Davis, Gregory Y.H. Lip
19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salim Yusuf Breakdown of academic impact, for papers by Gregg C. Fonarow Breakdown of academic impact, for papers by Deepak L. Bhatt Breakdown of academic impact, for papers by Eric D. Peterson Breakdown of academic impact, for papers by Philippe Gabríel Steg Breakdown of academic impact, for papers by Christopher B. Granger Breakdown of academic impact, for papers by Eugene Braunwald Breakdown of academic impact, for papers by Emelia J. Benjamin Breakdown of academic impact, for papers by Mary Cushman Breakdown of academic impact, for papers by Bernard J. Gersh
Rankless by CCL
2026